This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 May;6(5):687-9.

doi: 10.2217/fon.10.39.

Exploring a 'pro-senescence' approach for prostate cancer therapy by targeting PTEN

Manuel Collado¹

Affiliations

PMID: 20465384
DOI: 10.2217/fon.10.39

Comment

Exploring a 'pro-senescence' approach for prostate cancer therapy by targeting PTEN

Manuel Collado. Future Oncol. 2010 May.

. 2010 May;6(5):687-9.

doi: 10.2217/fon.10.39.

Author

Manuel Collado¹

Affiliation

¹ Spanish National Cancer Research Center (CNIO), 3 Melchor Fernandez Almagro Street, Madrid, Spain. mcollado@cnio.es

PMID: 20465384
DOI: 10.2217/fon.10.39

No abstract available

PubMed Disclaimer

Comment on

A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis.
Alimonti A, Nardella C, Chen Z, Clohessy JG, Carracedo A, Trotman LC, Cheng K, Varmeh S, Kozma SC, Thomas G, Rosivatz E, Woscholski R, Cognetti F, Scher HI, Pandolfi PP. Alimonti A, et al. J Clin Invest. 2010 Mar;120(3):681-93. doi: 10.1172/JCI40535. Epub 2010 Feb 8. J Clin Invest. 2010. PMID: 20197621 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Research Materials
- NCI CPTC Antibody Characterization Program